Loading...
XSTO
ACOU
Market cap7mUSD
Jul 22, Last price  
3.57SEK
1D
-2.46%
1Q
-10.75%
IPO
-82.84%
Name

Acousort AB

Chart & performance

D1W1MN
XSTO:ACOU chart
P/E
—
P/S
11.03
EPS
—
Div yield, %
—
Shrs. gr., 5y
10.03%
Rev. gr., 5y
6.82%
Revenues
7m
+44.67%
832,5471,947,1171,575,3492,722,0002,482,0001,074,0001,856,0004,928,0003,007,0004,963,00010,551,0004,737,0006,853,000
Net income
-12m
L-19.40%
-62,720108,009-278,849-830,000-6,072,000-8,960,000-9,683,000-8,220,000-12,381,000-13,211,000-17,089,000-15,078,000-12,153,000
CFO
-17m
L-10.78%
-3,012,000-8,597,000-757,000-214,000-8,525,000-7,397,000-9,843,000-7,035,000-10,918,0003,965,000-31,559,000-18,807,000-16,780,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy and other elements of the future automated systems. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden.
URL
https://acousort.com/
IPO date
Jan 09, 2017
Employees
13
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT